BIO-Europe Spring® 2017: Sofinnova chairman discusses entrepreneurial culture change in biotech

April 13, 2017

Antoine Papiernik is the chairman of Paris-based Sofinnova Partners, a venture capital firm that invests in startups and spinout biotech companies primarily in Europe. He spoke with Luke Timmerman, the founder and editor of Timmerman Report, a biotech industry newsletter, at BIO-Europe Spring in Barcelona about some of the cultural challenges facing startups in Europe.

 

Click here for more coverage of the activities held during BIO-Europe Spring

Previous Video
BIO-Europe Spring® 2017: Seventure Partners predicts bright future for microbiome opportunities
BIO-Europe Spring® 2017: Seventure Partners predicts bright future for microbiome opportunities

Seventure Partners’ Eric de la Fortelle explains to Informa Pharma Intelligence’s Mike Ward how the venture...

Next Video
BIO-Europe Spring® 2017: Prexton CEO on future for novel Parkinson's therapy
BIO-Europe Spring® 2017: Prexton CEO on future for novel Parkinson's therapy

As Prexton Therapeutics prepares to move its lead compound foliglurax into Phase II trials as a symptomatic...